Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 143

1.

Efficacy of gemcitabine plus platinum agents for biliary tract cancers: a meta-analysis.

Yang R, Wang B, Chen YJ, Li HB, Hu JB, Zou SQ.

Anticancer Drugs. 2013 Sep;24(8):871-7. doi: 10.1097/CAD.0b013e3283637292. Review.

PMID:
23799294
[PubMed - indexed for MEDLINE]
2.

Gemcitabine and oxaliplatin with or without erlotinib in advanced biliary-tract cancer: a multicentre, open-label, randomised, phase 3 study.

Lee J, Park SH, Chang HM, Kim JS, Choi HJ, Lee MA, Jang JS, Jeung HC, Kang JH, Lee HW, Shin DB, Kang HJ, Sun JM, Park JO, Park YS, Kang WK, Lim HY.

Lancet Oncol. 2012 Feb;13(2):181-8. doi: 10.1016/S1470-2045(11)70301-1. Epub 2011 Dec 20. Erratum in: Lancet Oncol. 2012 Feb;13(2):e49. Chang, Joung Soon [corrected to Jang, Joung Soon].

PMID:
22192731
[PubMed - indexed for MEDLINE]
Free Article
3.

Gemcitabine-based versus fluoropyrimidine-based chemotherapy with or without platinum in unresectable biliary tract cancer: a retrospective study.

Kim MJ, Oh DY, Lee SH, Kim DW, Im SA, Kim TY, Heo DS, Bang YJ.

BMC Cancer. 2008 Dec 18;8:374. doi: 10.1186/1471-2407-8-374.

PMID:
19091129
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

A retrospective study of chemotherapy with cisplatin plus gemcitabine after the failure of gemcitabine monotherapy for biliary tract cancer.

Kameda R, Ando T, Kobayashi S, Ueno M, Ohkawa S.

Jpn J Clin Oncol. 2013 Jun;43(6):636-40. doi: 10.1093/jjco/hyt059. Epub 2013 Apr 25.

PMID:
23619988
[PubMed - indexed for MEDLINE]
Free Article
5.

Outcome of patients receiving chemotherapy for advanced biliary tract or gallbladder carcinoma.

Cassier PA, Thevenet C, Walter T, Baulieux J, Scoazec JY, Bancel B, Adham M, Souquet JC, Ponchon T, Lombard-Bohas C.

Eur J Gastroenterol Hepatol. 2010 Sep;22(9):1111-7. doi: 10.1097/MEG.0b013e3283396dde.

PMID:
20386107
[PubMed - indexed for MEDLINE]
6.

Efficacy of gemcitabine plus platinum chemotherapy compared with other platinum containing regimens in advanced non-small-cell lung cancer: a meta-analysis of survival outcomes.

Le Chevalier T, Scagliotti G, Natale R, Danson S, Rosell R, Stahel R, Thomas P, Rudd RM, Vansteenkiste J, Thatcher N, Manegold C, Pujol JL, van Zandwijk N, Gridelli C, van Meerbeeck JP, Crino L, Brown A, Fitzgerald P, Aristides M, Schiller JH.

Lung Cancer. 2005 Jan;47(1):69-80.

PMID:
15603856
[PubMed - indexed for MEDLINE]
7.

Fluoropyrimidines plus cisplatin versus gemcitabine/gemcitabine plus cisplatin in locally advanced and metastatic biliary tract carcinoma - a retrospective study.

Croitoru A, Gramaticu I, Dinu I, Gheorghe L, Alexandrescu S, Buica F, Luca I, Becheanu G, Herlea V, Simionov I, Hrehoret D, Lupescu I, Popescu I, Diculescu M.

J Gastrointestin Liver Dis. 2012 Sep;21(3):277-84.

PMID:
23012669
[PubMed - indexed for MEDLINE]
Free Article
8.

A Phase II study of gemcitabine and cisplatin in advanced biliary tract cancer.

Kim ST, Park JO, Lee J, Lee KT, Lee JK, Choi SH, Heo JS, Park YS, Kang WK, Park K.

Cancer. 2006 Mar 15;106(6):1339-46.

PMID:
16475213
[PubMed - indexed for MEDLINE]
Free Article
9.

Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer.

Valle J, Wasan H, Palmer DH, Cunningham D, Anthoney A, Maraveyas A, Madhusudan S, Iveson T, Hughes S, Pereira SP, Roughton M, Bridgewater J; ABC-02 Trial Investigators.

N Engl J Med. 2010 Apr 8;362(14):1273-81. doi: 10.1056/NEJMoa0908721.

PMID:
20375404
[PubMed - indexed for MEDLINE]
Free Article
10.

Pemetrexed plus platinum or gemcitabine plus platinum for advanced non-small cell lung cancer: final survival analysis from a multicentre randomized phase II trial in the East Asia region and a meta-analysis.

Zhang X, Lu J, Xu J, Li H, Wang J, Qin Y, Ma P, Wei L, He J.

Respirology. 2013 Jan;18(1):131-9. doi: 10.1111/j.1440-1843.2012.02248.x.

PMID:
22882698
[PubMed - indexed for MEDLINE]
Free Article
11.

Gemcitabine for unresectable, locally advanced or metastatic bladder cancer.

Shelley M, Cleves A, Wilt TJ, Mason M.

Cochrane Database Syst Rev. 2011 Apr 13;(4):CD008976. doi: 10.1002/14651858.CD008976.pub2. Review.

PMID:
21491413
[PubMed - indexed for MEDLINE]
13.

FOLFOX-4 regimen or single-agent gemcitabine as first-line chemotherapy in advanced biliary tract cancer.

Novarino AM, Satolli MA, Chiappino I, Giacobino A, Napoletano R, Ceccarelli M, Ciccone G, Schena M, Bertetto O, Ciuffreda L.

Am J Clin Oncol. 2013 Oct;36(5):466-71. doi: 10.1097/COC.0b013e31825691c3.

PMID:
22781390
[PubMed - indexed for MEDLINE]
14.

A meta-analysis of platinum plus gemcitabine or vinorelbine in the treatment of advanced non-small-cell lung cancer.

Gao G, Jiang J, Liang X, Zhou X, Huang R, Chu Z, Zhan Q.

Lung Cancer. 2009 Sep;65(3):339-44. doi: 10.1016/j.lungcan.2008.11.019. Epub 2009 Jan 13.

PMID:
19144444
[PubMed - indexed for MEDLINE]
15.

Gemcitabine alone or in combination with Cisplatin for advanced biliary tract carcinomas: an overview of clinical evidence.

Sun TT, Wang JL, Fang JY.

Asian Pac J Cancer Prev. 2013;14(2):877-83.

PMID:
23621255
[PubMed - indexed for MEDLINE]
Free Article
16.

Chemotherapy for inoperable advanced or metastatic cholangiocarcinoma: retrospective analysis of 78 cases in a single center over four years.

Pracht M, Le Roux G, Sulpice L, Mesbah H, Manfredi S, Audrain O, Boudjema K, Raoul JL, Boucher E.

Chemotherapy. 2012;58(2):134-41. doi: 10.1159/000337289. Epub 2012 May 10.

PMID:
22572213
[PubMed - indexed for MEDLINE]
17.

Chemotherapy with gemcitabine plus cisplatin in patients with advanced biliary tract carcinoma at Chang Gung Memorial Hospital: a retrospective analysis.

Wu CE, Hsu HC, Shen WC, Lin YC, Wang HM, Chang JW, Chen JS.

Chang Gung Med J. 2012 Sep-Oct;35(5):420-7.

PMID:
23127347
[PubMed - indexed for MEDLINE]
Free Article
18.

Review of gemcitabine in biliary tract carcinoma.

Scheithauer W.

Semin Oncol. 2002 Dec;29(6 Suppl 20):40-5. Review.

PMID:
12577232
[PubMed - indexed for MEDLINE]
19.

Gemcitabine with carboplatin for advanced biliary tract cancers: a phase II single institution study.

Williams KJ, Picus J, Trinkhaus K, Fournier CC, Suresh R, James JS, Tan BR.

HPB (Oxford). 2010 Aug;12(6):418-26. doi: 10.1111/j.1477-2574.2010.00197.x.

PMID:
20662793
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Randomized phase III trial of gemcitabine plus cisplatin compared with gemcitabine alone in advanced pancreatic cancer.

Heinemann V, Quietzsch D, Gieseler F, Gonnermann M, Schönekäs H, Rost A, Neuhaus H, Haag C, Clemens M, Heinrich B, Vehling-Kaiser U, Fuchs M, Fleckenstein D, Gesierich W, Uthgenannt D, Einsele H, Holstege A, Hinke A, Schalhorn A, Wilkowski R.

J Clin Oncol. 2006 Aug 20;24(24):3946-52.

PMID:
16921047
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk